Network-assisted investigation of antipsychotic drugs and their targets (Q43836810)

27 November 2017

title

Network-assisted investigation of antipsychotic drugs and their targets (English)

1 reference

27 November 2017

Jingchun Sun

1 reference

27 November 2017

Hua Xu

series ordinal

1 reference

27 November 2017

Zhongming Zhao

series ordinal

1 reference

27 November 2017

publication date

1 May 2012

1 reference

Chemistry and Biodiversity

27 November 2017

published in

1 reference

27 November 2017

1 reference

27 November 2017

1 reference

27 November 2017

page(s)

900-910

1 reference

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Gene Expression Profiling in Rodent Models for Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Evidence that clozapine directly interacts on the GABAB receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Neuroreceptor imaging studies in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Cortical dopamine D2/D3 receptors are a common site of action for antipsychotic drugs--an original patient data meta-analysis of the SPECT and PET in vivo receptor imaging literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Meta-analysis of 32 genome-wide linkage studies of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Application of systems biology approach identifies and validates GRB2 as a risk gene for schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

dmGWAS: dense module searching for genome-wide association studies in protein-protein interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Network systems biology for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Network pharmacology: the next paradigm in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Network analyses in systems pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Identification of information flow-modulating drug targets: a novel bridging paradigm for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

DrugBank 3.0: a comprehensive resource for 'omics' research on drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

CS23D: a web server for rapid protein structure generation using NMR chemical shifts and sequence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

DrugBank: a comprehensive resource for in silico drug discovery and exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

UniProt Knowledgebase: a hub of integrated protein data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

The serotonin hypothesis of schizophrenia: a historical case study on the heuristic value of theory in clinical neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

The role of serotonin receptors in the action of atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Antipsychotic occupancy of dopamine receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

An automated method for finding molecular complexes in large protein interaction networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Cytoscape 2.8: new features for data integration and network visualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

CATIE and CUtLASS: can we handle the truth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Calcyon upregulation in adolescence impairs response inhibition and working memory in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Calcyon, a novel partner of clathrin light chain, stimulates clathrin-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Antipsychotic polypharmacy in schizophrenia: benefits and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Schizophrenia and increased risks of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Severe mental illness and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

Network biology: understanding the cell's functional organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCBDV.201100356

DrugBank: a knowledgebase for drugs, drug actions and drug targets

21 January 2018

1 reference

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1093/NAR/GKM958

Identifiers

DOI

10.1002/CBDV.201100356

1 reference

27 November 2017

1 reference